The Deaza dGTP 5 mM Solution, 2 µmol (27209002) is a 7-Deaza-2'-Deoxyguanosine 5'-Triphosphate nucleotide analogue supplied as a 5 mM liquid solution. This Deaza dGTP variant is supplied in a 2 µmol pack for sequencing and PCR-related workflows where substitution of dGTP can support work with GC-rich or compression-prone sequences.
Key Features
- 7-Deaza-dGTP nucleotide analogue, supplied as 7-Deaza-2'-Deoxyguanosine 5'-Triphosphate for molecular biology workflows
- 5 mM liquid solution, providing a ready-to-use concentration for nucleotide analogue applications
- 2 µmol pack size, matched to the verified Cytiva 27-2090-02 specification
- Colourless liquid format, with verified liquid form and colourless appearance
- Designed to reduce band compressions, supporting sequencing gel workflows affected by stable intra-strand secondary structures
- Useful for GC-rich sequence work, with feed-confirmed use in improving PCR yields and making GC-rich sequencing easier
- Cold-chain handling, with verified dry ice shipping and -20 °C storage requirements
Benefits
- Supports sequencing workflows where nucleotide analogue substitution is used to address compression artefacts.
- Helps laboratories work with GC-rich templates that can be challenging in PCR or sequencing workflows.
- Provides a defined 5 mM solution format for easier reagent setup compared with weighing and dissolving solids.
- Maintains product integrity through documented cold shipping and storage conditions.
Why Choose the Deaza dGTP 5 mM Solution, 2 µmol (27209002)?
The Deaza dGTP 5 mM Solution, 2 µmol (27209002) is suited to laboratories requiring a Cytiva nucleotide analogue for sequencing and PCR-related molecular biology workflows. John Morris Group supplies Cytiva genomics reagents to Australian laboratories with local product support.
